» Articles » PMID: 38241592

Breast Cancer: A Review of Risk Factors and Diagnosis

Overview
Specialty General Medicine
Date 2024 Jan 19
PMID 38241592
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer remains a complex and prevalent health concern affecting millions of individuals worldwide. This review paper presents a comprehensive analysis of the multifaceted landscape of breast cancer, elucidating the diverse spectrum of risk factors contributing to its occurrence and exploring advancements in diagnostic methodologies. Through an extensive examination of current literature, various risk factors have been identified, encompassing genetic predispositions such as BRCA mutations, hormonal influences, lifestyle factors, and reproductive patterns. Age, family history, and environmental factors further contribute to the intricate tapestry of breast cancer etiology. Moreover, this review delineates the pivotal role of diagnostic tools in the early detection and management of breast cancer. Mammography, the cornerstone of breast cancer screening, is augmented by emerging technologies like magnetic resonance imaging and molecular testing, enabling improved sensitivity and specificity in diagnosing breast malignancies. Despite these advancements, challenges persist in ensuring widespread accessibility to screening programs, particularly in resource-limited settings. In conclusion, this review underscores the importance of understanding diverse risk factors in the development of breast cancer and emphasizes the critical role of evolving diagnostic modalities in enhancing early detection. The synthesis of current knowledge in this review aims to contribute to a deeper comprehension of breast cancer's multifactorial nature and inform future directions in research, screening strategies, and preventive interventions.

Citing Articles

A comprehensive bioinformatic evaluation of the NTRK family's potential as prognostic biomarkers in breast cancer.

Mohammadi R, Ghiasi M, Mehdizadeh S, Mohammadi J, Mohammad Ganji S Bioinform Adv. 2025; 5(1):vbaf030.

PMID: 40061872 PMC: 11886811. DOI: 10.1093/bioadv/vbaf030.


Synthesis and biological evaluation of thiourea-tethered benzodiazepinones as anti-proliferative agents targeting JAK-3 kinase.

Dhawan B, Alam M, Hamid H, Yadav A, Akhter G, Dar M Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40029384 DOI: 10.1007/s00210-025-03853-1.


Study the Expression of Two Circular RNAs, hsa_circ_0003227 and hsa_circ_0001666, in the Primary Breast Cancer Cell Line BT-20 and the Metastatic Breast Cancer Cell Line MCF-7.

Absalan S, Vaziri H, Hadavi M Biochem Genet. 2025; .

PMID: 39976889 DOI: 10.1007/s10528-025-11051-0.


CD44-Receptors-Mediated Multiprong Targeting Strategy Against Breast Cancer and Tumor-Associated Macrophages: Design, Optimization, Characterization, and Cytologic Evaluation.

Hussain Z, Abdulrahim Abdul Moti L, Jagal J, Thu H, Khan S, Kazi M Int J Nanomedicine. 2025; 20:991-1020.

PMID: 39881963 PMC: 11776558. DOI: 10.2147/IJN.S480553.


Multifaceted barriers associated with clinical breast examination in sub-Saharan Africa: A multilevel analytical approach.

Ayebeng C, Okyere J, Okantey C, Addo I PLoS One. 2025; 20(1):e0316800.

PMID: 39804868 PMC: 11730425. DOI: 10.1371/journal.pone.0316800.


References
1.
Qaseem A, Snow V, Sherif K, Aronson M, Weiss K, Owens D . Screening mammography for women 40 to 49 years of age: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2007; 146(7):511-5. DOI: 10.7326/0003-4819-146-7-200704030-00007. View

2.
Moyer V . Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2013; 160(4):271-81. DOI: 10.7326/M13-2747. View

3.
Belachew E, Sewasew D . Molecular Mechanisms of Endocrine Resistance in Estrogen-Positive Breast Cancer. Front Endocrinol (Lausanne). 2021; 12:599586. PMC: 8030661. DOI: 10.3389/fendo.2021.599586. View

4.
Sun Y, Zhao Z, Yang Z, Xu F, Lu H, Zhu Z . Risk Factors and Preventions of Breast Cancer. Int J Biol Sci. 2017; 13(11):1387-1397. PMC: 5715522. DOI: 10.7150/ijbs.21635. View

5.
Kim M, Jung M . Effects of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Structural Equation Approach With the Theory of Unpleasant Symptoms. Cancer Nurs. 2019; 44(2):145-153. DOI: 10.1097/NCC.0000000000000764. View